Lensar (LNSR) Times Interest Earned (2019 - 2020)
Lensar (LNSR) reported Times Interest Earned of -$72.49 for Q3 2020, down 571.0% year-over-year from $15.39 in Q4 2019, and down 1165.74% on a QoQ basis from -$5.73 in Q2 2020.
Lensar (LNSR) has 2 years of Times Interest Earned data on file, last reported at -$72.49 in Q3 2020.
- Quarterly Times Interest Earned fell 571.0% year-over-year to -$72.49 in Q3 2020, while the trailing twelve-month figure through Jun 2021 was -$325.15 (down 5215.5% YoY) and the FY2020 annual result came in at -$13.81, down 117.31% from the prior year.
- Times Interest Earned declined to -$72.49 in Q3 2020 per LNSR's latest filing, from -$5.73 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$3.49 in Q4 2019 and bottomed at -$72.49 in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.73 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.09 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.23 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -2.90 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 5.36 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 20.98 |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -72.49 |
| Jun 30, 2020 | -5.73 |
| Mar 31, 2020 | -5.13 |
| Dec 31, 2019 | -3.49 |
| Sep 30, 2019 | -10.80 |